Impact of anti-vaccine movements on pertussis control: the untold story - PubMed

Impact of anti-vaccine movements on pertussis control: the untold story

E J Gangarosa et al. Lancet. 1998.

Abstract

To assess the impact of anti-vaccine movements that targeted pertussis whole-cell vaccines, we compared pertussis incidence in countries where high coverage with diphtheria-tetanus-pertussis vaccines (DTP) was maintained (Hungary, the former East Germany, Poland, and the USA) with countries where immunisation was disrupted by anti-vaccine movements (Sweden, Japan, UK, The Russian Federation, Ireland, Italy, the former West Germany, and Australia). Pertussis incidence was 10 to 100 times lower in countries where high vaccine coverage was maintained than in countries where immunisation programs were compromised by anti-vaccine movements. Comparisons of neighbouring countries with high and low vaccine coverage further underscore the efficacy of these vaccines. Given the safety and cost-effectiveness of whole-cell pertussis vaccines, our study shows that, far from being obsolete, these vaccines continue to have an important role in global immunisation.

Similar articles

• Developments in pertussis immunisation in Japan.

  Kimura M, Kuno-Sakai H. Kimura M, et al. Lancet. 1990 Jul 7;336(8706):30-2. doi: 10.1016/0140-6736(90)91530-n. Lancet. 1990. PMID: 1973217

• A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.

  Greco D, Salmaso S, Mastrantonio P, Giuliano M, Tozzi AE, Anemona A, Ciofi degli Atti ML, Giammanco A, Panei P, Blackwelder WC, Klein DL, Wassilak SG. Greco D, et al. N Engl J Med. 1996 Feb 8;334(6):341-8. doi: 10.1056/NEJM199602083340601. N Engl J Med. 1996. PMID: 8538704 Clinical Trial.

• Control of pertussis in the world.

  Galazka A. Galazka A. World Health Stat Q. 1992;45(2-3):238-47. World Health Stat Q. 1992. PMID: 1462658 Review.

• Recommendations to control pertussis prioritized relative to economies: A Global Pertussis Initiative update.

  Forsyth KD, Tan T, von König CW, Heininger U, Chitkara AJ, Plotkin S. Forsyth KD, et al. Vaccine. 2018 Nov 19;36(48):7270-7275. doi: 10.1016/j.vaccine.2018.10.028. Epub 2018 Oct 15. Vaccine. 2018. PMID: 30337176 Review.

Cited by

• COVID-19 Vaccine Hesitancy among Population in Jazan Region of Saudi Arabia.

  Almalki M, Sultan MK, Abbas M, Alhazmi A, Hassan Y, Varghese J. Almalki M, et al. Healthcare (Basel). 2023 Nov 27;11(23):3051. doi: 10.3390/healthcare11233051. Healthcare (Basel). 2023. PMID: 38063619 Free PMC article.

• Validity and reliability of Turkish version of the Vaccine Hesitancy Scale.

  Önal Ö, Eroğlu HN, Evcil FY, Kişioğlu AN, Uskun E. Önal Ö, et al. Turk Arch Pediatr. 2021 May 1;56(3):230-235. doi: 10.5152/TurkArchPediatr.2021.20028. eCollection 2021. Turk Arch Pediatr. 2021. PMID: 34104914 Free PMC article.

• Delays in immunization have potentially serious health consequences.

  Guerra FA. Guerra FA. Paediatr Drugs. 2007;9(3):143-8. doi: 10.2165/00148581-200709030-00002. Paediatr Drugs. 2007. PMID: 17523694

• Vaccination and the theory of games.

  Bauch CT, Earn DJ. Bauch CT, et al. Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13391-4. doi: 10.1073/pnas.0403823101. Epub 2004 Aug 25. Proc Natl Acad Sci U S A. 2004. PMID: 15329411 Free PMC article.

• Communicating with Patients about COVID-19 Vaccination: A Qualitative Study on Vaccinators in Tuscany Region, Italy.

  Alderotti G, Corvo MF, Buscemi P, Stacchini L, Giorgetti D, Lorini C, Bonaccorsi G, Pinilla MJC, Lastrucci V. Alderotti G, et al. Vaccines (Basel). 2023 Jan 19;11(2):223. doi: 10.3390/vaccines11020223. Vaccines (Basel). 2023. PMID: 36851101 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Ovid Technologies, Inc.

• Medical

  • MedlinePlus Health Information